Patents by Inventor Kerry Jenkins

Kerry Jenkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250013942
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Application
    Filed: September 19, 2024
    Publication date: January 9, 2025
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Publication number: 20240028980
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Application
    Filed: October 4, 2023
    Publication date: January 25, 2024
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Publication number: 20220261709
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 18, 2022
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Patent number: 11354605
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Grant
    Filed: January 22, 2020
    Date of Patent: June 7, 2022
    Assignee: INNOVATIVE LOGISTICS, INC.
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Publication number: 20200160236
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Application
    Filed: January 22, 2020
    Publication date: May 21, 2020
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Patent number: 10562882
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, in which R1, R2, R3, R4 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: February 18, 2020
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Anne Goldby, Kerry Jenkins, Martin Teall
  • Publication number: 20190295010
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Application
    Filed: June 10, 2019
    Publication date: September 26, 2019
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Patent number: 10287286
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, Y1, Y2, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: May 14, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Saleh Ahmed, Gregory Barker, Hannah Canning, Richard Davenport, David Harrison, Kerry Jenkins, David Livermore, Susanne Wright, Natasha Kinsella
  • Publication number: 20190057331
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Application
    Filed: October 24, 2018
    Publication date: February 21, 2019
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Patent number: 10160745
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R1, R2, R3 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions N containing them and their use in therapy.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: December 25, 2018
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Sarah Bousba, Anne Goldby, Kerry Jenkins, Natasha Kinsella, Martin Teall
  • Patent number: 10147059
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: December 4, 2018
    Assignee: INNOVATIVE LOGISTICS, INC.
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Publication number: 20180121864
    Abstract: Disclosed herein is an automated cross-dock management system configured to optimize moves on a cross-dock. The automated cross-dock management system uses inbound manifest data to calculate ordered move instructions for all inbound movable platforms, inbound modular decks, and inbound freight. The ordered move instructions can be assigned to be carried out by manual conveyance vehicles or by automated guided vehicles based upon a plurality of criteria. The automated cross-dock management system is also able to detect damaged freight on the cross-dock using a combination of streams from video cameras.
    Type: Application
    Filed: October 31, 2017
    Publication date: May 3, 2018
    Inventors: Patrick Sullivan, Jefferson Maldonado, Shannon Lively, Kerry Jenkins, Jonathan McCormack, Jeremy Sloan
  • Publication number: 20180072714
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, Y1, Y2, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: March 17, 2016
    Publication date: March 15, 2018
    Inventors: Saleh Ahmed, Gregory Barker, Hannah Canning, Richard Davenport, David Harrison, Kerry Jenkins, David Livermore, Susanne Wright, Natasha Kinsella
  • Publication number: 20180009780
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R1, R2, R3 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions N containing them and their use in therapy.
    Type: Application
    Filed: September 12, 2017
    Publication date: January 11, 2018
    Inventors: Sarah Bousba, Anne Goldby, Kerry Jenkins, Natasha Kinsella, Martin Teall
  • Patent number: 9790201
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R1, R2, R3 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: October 17, 2017
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Sarah Bousba, Anne Goldby, Kerry Jenkins, Natasha Kinsella, Martin Teall
  • Publication number: 20170166553
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, in which R1, R2, R3, R4 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: November 26, 2014
    Publication date: June 15, 2017
    Inventors: Anne Goldby, Kerry Jenkins, Martin Teall
  • Patent number: 9433622
    Abstract: Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases associated with aberrant activity of the protein kinases IKK? and/or TBK-1 in which one of V and W is N, and the other of V and W is C—H; and R1, R2, R3 and R4 are as defined in the specification. The invention also provides uses of the compounds and compositions containing them.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: September 6, 2016
    Assignee: Case Western Reserve University
    Inventors: Gary Karl Newton, Mark Richard Stewart, Trevor Robert Perrior, Stuart Richard Crosby, Anna Hopkins, Gabriel Negoita-Giras, Kerry Jenkins
  • Publication number: 20160000784
    Abstract: Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases associated with aberrant activity of the protein kinases IKK? and/or TBK-1 in which one of V and W is N, and the other of V and W is C—H; and R1, R2, R3 and R4 are as defined in the specification. The invention also provides uses of the compounds and compositions containing them.
    Type: Application
    Filed: February 21, 2014
    Publication date: January 7, 2016
    Applicant: DOMAINEX LIMITED
    Inventors: Gary Karl Newton, Mark Richard Stewart, Trevor Robert Perrior, Stuart Richard Crosby, Anna Hopkins, Gabriel Nefoita-Giras, Kerry Jenkins
  • Patent number: 8653272
    Abstract: A series of heteroaryl-substituted fused pyridine derivatives, in particular heteroaryl-substituted thieno[3,2-6]pyridine derivatives, being selective inhibitors of PO kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
    Type: Grant
    Filed: October 21, 2009
    Date of Patent: February 18, 2014
    Assignee: UCB Pharma S.A.
    Inventors: Kerry Jenkins, Christopher James Lock, Andrew James Ratcliffe
  • Patent number: 8637453
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain pyruvamide compounds of the following formula (for convenience, collectively referred to herein as “PVA compounds”), which, inter alia, inhibit a dust mite Group 1 peptidase allergen (e.g., Der p 1, Der f 1, Eur m 1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit a dust mite Group 1 peptidase allergen, and in the treatment of diseases and disorders that are mediated by a dust mite Group 1 peptidase allergen; that are ameliorated by the inhibition of a dust mite Group 1 peptidase allergen; asthma; rhinitis; allergic conjunctivitis; atopic dermatitis; an allergic condition which is triggered by dust mites; an allergic condition which is triggered by a dust mite Group 1 peptidase allergen; and canine atopy.
    Type: Grant
    Filed: March 28, 2013
    Date of Patent: January 28, 2014
    Assignees: St George's Hospital Medical School, The University of Manchester
    Inventors: Clive Robinson, Jihui Zhang, David Ronald Garrod, Trevor Robert Perrior, Gary Karl Newton, Kerry Jenkins, Rebekah Elisabeth Key, Meriel Ruth Major, Mark Richard Stewart